TracerDX, Inc.
Biotechnology company · New York, United States
TracerDX, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $7.9 million sold in a notice filed in 2024.
TracerDX at a glance
What does TracerDX do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7.9 million sold (2024).
Frequently asked questions about TracerDX
Where is TracerDX headquartered?
TracerDX, Inc. is headquartered in New York, United States.
What does TracerDX do?
TracerDX, Inc. is a biotechnology company.
When was TracerDX founded?
The earliest incorporation on record for TracerDX, Inc. is in 2021, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences